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Summary festation of the condition can range from mild disease
with transient hypertension in the latter part of preg-
Pregnancy-induced hypertension may be regarded as a nancy to life-threatening illness with convulsions in
manifestation of endothelial-cell dysfunction. The role hypertensive pregnancy, thrombocytopenia, HELLP
of the eNOS gene in the development of a familial preg- (hemolysis, elevated liver enzymes, and low platelets)
nancy-induced hypertension was evaluated by analysis syndrome, and fetal hypoxia and growth retardation.
of linkage among affected sisters and in multiplex fami- Most of the pathophysiological changes, such as hyper-
lies (n Å 50). Markers from a 4-cM region encoding the tension, volume contraction, platelet exhaustion, dis-
eNOS gene showed distortion from the expected allele seminated intravascular coagulation, and enhanced vas-
sharing among affected sisters (P Å .001–.05), and the cular reactivity, can be related to endothelial-cell
statistic obtained from the multilocus application of the dysfunction (Roberts and Redman 1993). The endothe-
affected-pedigree-member method also showed distor- lial dysfunction could be mediated by circulating fac-
tion (T[f(P)!sqrt(P)] Å 3.53; P õ .001). A LOD score of tor(s) originating from the placenta. Inherent abnormali-
3.36 was obtained for D7S505 when a best-ﬁtting model ties in the vascular endothelium are equally likely to be
derived from genetic epidemiological data was used, and a contributing cause in the familial form of the disease.
LOD scores of 2.54–4.03 were obtained when various In both situations abnormalities in a ﬁnal common path-
other genetic models were used. Estimates of recombina- way, leading to impairment of endothelial function,
tion rate, rather than maximum LOD-score values, were would be anticipated.
affected by changes in the genetic parameters. The trans- Constitutive nitric oxide (NO) production in endothe-
mission-disequilibrium test, a model-free estimate of lial cells increases during pregnancy and contributes to
linkage, showed strongest association and linkage with vasodilatation and blunting of vasopressor response
a microsatellite within intron 13 of the eNOS gene (P (Goetz et al. 1994; Nathan et al. 1995). Evidence forÅ .005). These results support the localization of a fa- the role of NO in the pathogenesis of pregnancy-induced
milial pregnancy-induced hypertension–susceptibility hypertension comes from both animal and human stud-
locus in the region of chromosome 7q36 encoding the ies. In women developing pregnancy-induced hyperten-
eNOS gene. sion NO generation has been shown to be inappropri-
ately low (Delacretaz et al. 1995), and administration
of a NO donor improves ﬂow in the uterine artery inIntroduction
normal early pregnancy and in women at high risk of
Pregnancy-induced hypertension or preeclampsia syn- developing the disease (Ramsay et al. 1994). Inhibition
drome is a major cause of maternal and fetal morbidity of NO synthesis in animals during pregnancy produces
and mortality. The majority of cases are sporadic, but hypertension, proteinuria, thrombocytopenia, and fetal
a familial pregnancy-induced hypertensive disorder has growth retardation (Yallampalli and Garﬁeld 1993;
been described (Cooper and Liston 1979; Chesley and Molnar et al. 1994). These ﬁndings make the endothelial
Cooper 1986; Arngrı´msson et al. 1990). Clinical mani- NO synthase (eNOS) gene a primary candidate for the
familial pregnancy-induced hypertension syndrome.
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family form might unmask a tendency toward hyperten- severe pregnancy-induced hypertensive disease and from
42 women with either mild or possibly pregnancy-in-sion later in life. Later, Humphries (1960), Cooper and
Liston (1979), and Chesley and Cooper (1986) further duced hypertension who were from 50 families from
Scotland and Iceland. Males were classiﬁed as unknowndeﬁned the condition. Although in the original descrip-
tions of the families the probands invariably had severe in all analyses. Women with blood pressureõ90 mmHg
during pregnancy were classiﬁed as normal. Womendisease deﬁned as both elevated blood pressure (ú140/
90 mmHg) in pregnancy and proteinuria (then most who fell into the mild-disease category were classiﬁed
as affected in the ﬁrst run of the statistical analysis, alongoften called ‘‘severe preeclampsia’’), a considerable pro-
portion of other female members of the families who with those with the severe condition, but were classiﬁed
as unknown in the second analysis of the data. Outcomewere classiﬁed as affected had only hypertension with-
out proteinuria. For example, in the study by Chesley of ﬁrst pregnancy was used to determine disease status.
The diagnosis was based on information available at theand Cooper (1986) nearly half of the affected women
did not have any recording of proteinuria and were clas- time of the pregnancy, rather than on later follow-up
health assessments with respect to either developmentsiﬁed as having mild preeclamptic disease. It has been
suggested that having only one component of the syn- of recurrent disease or tendency toward subsequent car-
diovascular problems. No attempt was made to obtaindrome is not diagnostic, but its absence never excludes
the diagnosis with certainty (Redman 1989). Therefore conﬁrmation of prepregnancy blood-pressure readings
for these women (many had never had blood-pressureit can only be claimed that women with a single sign of
the syndrome, such as gestational hypertension alone, measurements done before their ﬁrst pregnancy), and,
as far as was possible, those with preexisting renal andmay possibly have the syndrome.
‘‘Preeclampsia,’’ ‘‘preeclamptic toxemia,’’ ‘‘preg- hypertensive disease were excluded. Approval for the
study was obtained from local ethics committees andnancy-induced hypertension,’’ ‘‘hypertensive disease of
pregnancy,’’ and ‘‘gestosis’’ are roughly synonymous the Icelandic Data Protection Committee.
terms describing various aspects of transient hyperten-
Markerssion in late gestation. The condition cannot at the mo-
ment be stereotyped, and the balance of its different Molecular-genetic analyses were performed by means
of microsatellite ampliﬁcations using methods describedcomponents will vary from case to case. One woman
may have severe hypertension but little renal involve- elsewhere (Nadaud et al. 1994). A CA repeat from in-
tron 13 of the eNOS gene was used in the ﬁrst phase ofment, another severe renal involvement but little hyper-
tension, and a third predominantly hepatic involvement. the study, and in the second phase two ﬂanking
Ge´ne´thon markers (D7S505/AFM199Zd4 and D7S483/It may even be possible to have preeclampsia without
hypertension (Redman et al. 1977). The simplest deﬁni- AFM074Xg5) were added (Weissenbach et al. 1992). To
ensure consistency, in the analysis of the PCR products,tion of the syndrome is therefore a pregnancy-speciﬁc
syndrome characterized by a group of signs of which at between laboratories, CEPH individual 1347.02 was ge-
notyped, and these alleles were used for reference. Thisleast two must be present (Redman 1989). These could,
for example, be either hypertension and proteinuria or individual is heterozygous for the presence of 31 and 32
CA repeats in the eNOS gene, which are denoted alleleshypertension and convulsions, since eclampsia can occur
without proteinuria (Sibai et al. 1981). Our classiﬁca- 13 and 14. At D7S505 he has alleles 1 and 5 (262/279
bp), at D7S483 alleles 8 and 9 (180/182 bp).tion scheme has taken the aforementioned considera-
tions into account, and women were classiﬁed as having
Mapping Strategy and Statistical Evaluationsevere pregnancy-induced hypertensive disease if they
developed during pregnancy at least one of the following The main effort of the collaborative group lies in link-
age analysis of putative candidate genes for the familialclinical signs: proteinuria (equivalent to §1/ on dip-
stick), convulsions (eclampsia), or intrauterine growth pregnancy-induced hypertension syndrome. The strat-
egy is based on analysis of highly informative microsatel-retardation, in addition to gestational hypertension (dia-
stolic blood pressure §90 mmHg after 20 wk of preg- lites within or in the vicinity of the putative gene, fol-
lowed by analyses of ﬂanking markers if the initialnancy). Hospital records were veriﬁed for all family
members who fell into this category. First- or second- analysis is suggestive of possible linkage. Because of the
complexity of the genetics of pregnancy-induced hyper-degree relatives of the probands who developed only a
single symptom, such as hypertension, after 20 wk of tension, our main emphasis is on the use of nonparamet-
ric analytical tools (for which no assumption has to bepregnancy, as well as those who stated that they had
developed the severe disease but for whom the relevant made about the inheritance of the trait) to estimate evi-
dence for linkage, followed by more-traditional, LOD-hospital records were not found, were classiﬁed as hav-
ing mild or possibly pregnancy-induced hypertension. In score calculations. The nonparametric arsenal for link-
age analyses included sib-pair analysis identical by de-this study, genotyping was performed on DNA samples
from 106 women who fulﬁlled the above criteria for scent (IBD) as implemented in the SIBPAIR program
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(Kuokkanen et al. 1996; Satsangi et al. 1996), the trans- hood method, where l is constrained to be ú.5 and l
Å .5 is the null hypothesis. 02ln[L(l)/L(l Å .5)] is as-mission-disequilibrium test (TDT) (Spielman et al. 1993;
Terwilliger 1995), and the affected-pedigree-member sumed to be asymptotically distributed as a x2 statistic
with 1 df. In multiplex families the TDT test can be used(APM) method (Weeks and Lange 1992). In the SIB-
PAIR program the number of sib pairs is weighted ac- to test the hypothesis of no linkage, but only limited
information about allelic association can be obtained.cording to the number of sibships (Blackwelder and Els-
ton 1985). These methods were developed to detect LOD-score calculations using genetic parameters
from previous genetic epidemiological studies were per-distortion of independent segregation of the marker and
a trait among affected relatives, without having to make formed by use of the FASTLINK 2.3P version (Cot-
tingham et al. 1993) of the LINKAGE package (Lathropassumptions about the mode of inheritance involved in
the trait. When applied to sib pairs the sharing of 0, 1, et al. 1984), ﬁrst by use of parameters from our recent
study, which supported multifactorial inheritance or aor 2 alleles is estimated, as are sharing and nonsharing
of parental alleles. In the latter application the expected major autosomal dominant gene with low penetrance
(i.e., the AD/LP model) (Arngrı´msson et al. 1995). Sec-50% chance of sharing the parental allele IBD is com-
pared with the observed values, by x2 calculations. More ond, other genetic models, derived from older data, were
also used, since these have been applied in previous ge-information is obtained from the data by use of this
latter procedure than by the 0, 1, 2 method, because, if netic-linkage studies: these models were as follows (q
Å gene frequency; f Å penetrance): (1) autosomal reces-a parent is homozygous, the sib pair cannot be classiﬁed
IBD by the 0, 1, 2 method, and the data are left out sive inheritance with complete penetrance—qÅ .2; fA1A2
Å fA2A2 Å 1.0 (Cooper and Liston 1979; Chesley andwhereas the sharing/nonsharing data from the other par-
ent (if heterozygous) can be fully informative. The APM Cooper 1986); (2) autosomal recessive with incomplete
penetrance—q Å .39; fA1A2 Å fA2A2 Å .41) (Liston andmethod is based on the same principles, but it can be
applied to extended or multiplex families. In this analy- Kilpatrick 1991); (3) a genetic model with partial domi-
nance—qÅ .1; fA1A2 Å .21 and fA2A2 Å 1.0, derived fromsis identity by state (IBS), rather than the IBD method
of comparison, is used, which makes it sensitive to allele- Arngrı´msson et al. (1995); (4) an arbitrary autosomal
dominant model with 90% penetrance—q Å .02; fA1A2frequency estimation. It has therefore become a custom
to use a different allele-weighting function in the analy- Å fA2A2 Å .90; and (5) affecteds-only analysis—that is,
a low-penetrance model for autosomal dominant inheri-sis. In this study the results are presented with the f(p)
Å sqrt(p), function, as recommended, as well as with no tance—q Å .02; fA1A2 Å fA2A2 Å .01. Two-point LOD-
score calculations were performed by use of both equalweighting, f(p) Å 1 (Weeks and Lange 1992).
The results were also analyzed with the TDT (Spiel- frequency for all alleles at the marker locus and allele
frequencies estimated from the families by use of theman et al. 1993). This test estimates the transmission of
a given allele from heterozygous parents to their affected ILINK module of the linkage programs.
offspring. The TDT statistic is formulated as (x 0 y)2/
(x/ y), which is asymptotically distributed as a x2 statis- Results
tic with 1 df. To perform the TDT analysis the TDTLIKE
Analysis of the eNOS Geneprogram was used (Terwilliger 1995). In the program,
exact P values from binomial distribution were com- A highly polymorphic microsatellite marker from in-
tron 13 of the eNOS gene was used for genotyping (Na-puted by a look at the probability of having the allele
under study transmitted §x times, of a total of (x / y) daud et al. 1994). ASP analyses were performed by use
of either only those affected women with the more se-opportunities, to the affected children of heterozygous
parents. Also, correction for multiple testing has been cure diagnosis of severe pregnancy-induced hypertensive
disease or all affected women (i.e., including also thoseimplemented in the program. Therefore the P values
presented reﬂect the probability that such results occur with possible or mild disease). For both classiﬁcation
schemes, distortion from the expected 50:50 transmis-for one of the n alleles at a given locus, rather than
assuming that only one single allele had been tested. sion of parental alleles was observed (P õ .001–.02)
(table 1). Analysis of sib pairs with one affected andOnly alleles that have at least ﬁve opportunities to be
transmitted were included, to reduce, in an unbiased one unaffected individual did not show any evidence of
segregation distortion, with 27/28 sharing/nonsharingway, the number of necessary tests to correct for. A
likelihood ratio–based TDT test that considers all the (P Å .48). LOD-score calculations with equal allele fre-
quency and using the AD/LP model (q Å .1; f Å .3) withalleles jointly, with one being transmitted preferentially
to affected offspring and the other not being so transmit- sex-average recombination showed a maximum LOD
score (Zmax) of 2.45 at theta (u) Å .08. This geneticted, as implemented in the TDTLIKE program, was also
used for linkage analysis (Terwilliger 1995). The proba- model has previously shown the best goodness of ﬁt to
combined genetic epidemiological data from the Unitedbility that any given allele is transmitted is called
‘‘lambda’’ (l) and is estimated by the maximum-likeli- States, Scotland, and Iceland (Arngrı´msson et al. 1995).
/ 9a30$$au01 08-05-97 18:30:39 ajhgal UC-AJHG
357Arngrı´msson et al.: Pregnancy-Induced Hypertension and eNOS Gene
Table 1
Affected-Sib-Pair Analyses Using Chromosome 7 Markers
NO. OF SIB PAIRS IN
WHOM PARENTAL
NO. OF SIB-PAIRS SHARINGa ALLELES AREb SIGNIFICANCE
MARKER No Alleles One Allele Two Alleles Shared Not Shared x2 c P
Severe or mild (possible) disorder:
D7S505 4 11 12 52 30 5.90 .009
eNOS 9 24 19 67 44 4.77 .015
D7S483 7 12 15 52 34 3.77 .026
Severe disorder only:
D7S505 1 7 9 37 15 9.31 .001
eNOS 5 15 12 44 26 4.63 .020
D7S483 5 8 10 34 21 3.08 .050
a Expected ratios are .25, .50, and .25 for no alleles, one allele, and two alleles, respectively.
b Expected shared:nonshared ratio is 50:50.
c Measurement of deviation from expected 50:50 shared:nonshared ratio.
When only information from the affected individuals (q gested have mainly involved some variation of autoso-
mal recessive inheritance. We have therefore repeatedÅ .1; f Å .01) was used, Zmax Å 2.63 at u Å .06 was
the LOD-score calculations, using several genetic-pa-obtained. When the recombination rate was allowed to
rameter models for D7S505, which showed the strongestvary with gender, Zmax increased to 2.73 at uf Å .02,
association in previous steps of the analysis. For thesewith a gender ratio of .1.
ﬁve models, Zmax Å 2.54-4.03 at u Å .00–.16 (table 3).
Analyses of eNOS and Flanking Markers The Zmax of 4.03 was obtained by use of a model with
In light of the suggestive results from the eNOS(CA)n partial dominance (q Å .10; fA1A2 Å .21 and fA2A2 Å 1.0),
analysis, the two nearest ﬂanking markers, D7S505 and which previously had shown slightly worse ﬁt to the
D7S483, which map the eNOS gene to a 4-cM region combined genetic epidemiological data from Iceland and
on chromosome 7q36, were used for further analysis. Scotland thanwas seenwith theAD/LPmodel (Arngrı´ms-
Affected-sib-pair analyses of both these markers showed son et al. 1995). The lowest LOD score was found by
distortion from the expected 50:50 transmission of the use of an autosomal recessive model with reduced pene-
parental alleles IBD, for both diagnostic-threshold levels trance (q Å .39; f Å .41), which is an approximation
used in the study. The signiﬁcance level ranged from P for analysis of the maternal component of the Liston
õ .001 to P õ .05 (table 1). Two-point LOD-score and Kilpatrick (1991) model, where it was suggested
analyses were performed for all three markers by use of that the mother and fetus are homozygous for the same
allele frequencies estimated from the families and sex- molecular aberration. Autosomal recessive inheritance
averaged recombination. When the AD/LP model was with full penetrance (q Å .20; f Å 1.0) was suggested
used in the calculation, Zmax was found for marker by Cooper and Liston (1979), and several publications
have supported their ﬁndings (Chesley and CooperD7S505—Zmax Å 3.36 at u Å .00—followed by eNOS-
1986; Arngrı´msson et al. 1990). Although, in the com-(CA)n , with Zmax Å 2.44 at u Å .06 (table 2), which is
bined genetic epidemiological analysis, this modelsimilar to that estimated when equal frequency is as-
showed signiﬁcantly worse ﬁt than was seen with thesigned to each allele. The Zmax for D7S483 was 1.05 at
AD/LP model, we have included this in our LOD-scoreu Å .14. When the analyses were restricted to women
calculations, because this model has been used in previ-diagnosed in accordance with the more strict classiﬁca-
ous linkage studies (Wilton et al. 1990; Hayward et al.tion of severe pregnancy-induced hypertensive disease,
1992; Arngrı´msson et al. 1994). Zmax Å 2.77 at u Å .16with exclusion of women with a possible or mild form
was observed for this model, supporting possible local-of the disease, the Zmax of 3.15 was observed for
ization of a familial pregnancy-induced hypertensionD7S505; for eNOS(CA)n Zmax Å 1.95, and for D7S483
susceptibility locus in the eNOS-gene region. LOD-scoreZmax Å 0.95 (table 2).
values were also calculated by use of an arbitrary au-
Effect of Genetic Parameters on LOD-Score Estimation tosomal dominant–gene model with high penetrance (q
During the past 30 years several hypotheses have been Å .02; f Å .9), under the assumption that we might be
put forward to explain the familial clustering of preg- studying a relatively rare form of pregnancy-induced
hypertension running in families. For this model, Zmaxnancy-induced hypertension. The genetic models sug-
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Table 2
Analyses Using Genetic Parameters from Previous Genetic-Epidemiological Study
(i.e., AD/LP Model [q Å .10; f Å .30])
Z AT u Å
MARKER .00 .01 .05 .10 .20 .30 .40 Zmax umax
Severe or mild (possible) disorder:
D7S505 3.36 3.33 3.14 2.79 1.90 .99 .31 3.36 .00
eNOS 1.96 2.11 2.42 2.37 1.69 .86 .23 2.44 .06
D7S483 .62 .76 1.12 1.27 1.08 .63 .21 1.05 .14
Severe disorder only:
D7S505 3.15 3.09 2.78 2.36 1.49 .72 .19 3.15 .00
eNOS 1.80 1.86 1.95 1.83 1.27 .64 .18 1.95 .04
D7S483 .73 .80 .94 .94 .69 .34 .19 .95 .08
Å 3.53 at u Å .12. Finally, Zmax Å 2.96 at u Å .00 was tion of allele segregation in the Scottish than was seen
in the Icelandic data (ﬁg. 1). The TDT results of theobtained for affecteds-only analysis (q Å .1; f Å .01).
eNOS(CA)n marker showed that the distortion of trans-
Nonparametric Linkage Analyses of Nuclear and mission of allele 14 was most signiﬁcant in both popula-
Multiplex Families tions, and again the Scottish data contributed more to
Nonparametric linkage analysis using the TDT test the deviance (table 4). When the TDT likelihood differ-
(Terwilliger 1995) and the APM method (Weeks and ences for the three markers were examined, the maxi-
Lange 1992) was performed with both nuclear and mul- mum distortion was observed for the eNOS(CA)n
tiplex families and with the analysis restricted to women marker, rather than for the two ﬂanking markers (ﬁg. 1).
with severe disease. The former test looks at all affected The more conservative approach of multilocus analysis,
offspring of heterozygous parents and compares the fre- rather than the single-locus module, of the APM pro-
quency at which they transmit any allele to their affected gram was also used, showing further evidence for distor-
offspring with the frequency at which they transmit the tion, from independent segregation of the marker alleles
other alleles to their affected children. Further support in these families (T[fp)Åsqrt(p)] Å 3.53; P õ .001; and
for linkage was obtained for the intragenic marker eN- T[fp)Å1] Å 4.69 (P õ .001).
OS(CA)n (lTDT Å .89; 02ln(L) difference Å 6.43; P
Å .005), whereas results for markers D7S505 and Discussion
D7S483 did not reach a signiﬁcant level (lTDT Å .75;
02ln(L) difference Å 2.55; P Å .055 and lTDT Å .55; Many common diseases, such as diabetes, ischemic
heart disease, multiple sclerosis, and schizophrenia, are02ln(L) difference Å 0.01; P Å .47, respectively). The
TDT results from both populations were in good agree- likely to be etiologically and genetically heterogeneous,
which means that the same clinical disorder is caused byment, but more of the deviance was attributed to distor-
Table 3
Two-Point Z Analyses Using D7S505 and Various Genetic Parameters
Z AT u Å
MODELa .00 .01 .05 .10 .20 .30 .40 Zmax qmax
1 0 06.01 .24 2.22 2.66 1.69 .56 2.77 .16
2 2.52 2.54 2.48 2.25 1.54 .80 .24 2.54 .02
3 4.03 4.01 3.82 3.43 2.36 1.24 .38 4.03 .00
4 .34 1.12 2.79 3.48 3.11 1.88 .63 3.53 .12
5 2.96 2.94 2.78 2.47 1.68 .89 .29 2.96 .00
a 1 Å Autosomal recessive with complete penetrance, as suggested by Chesley and Cooper (1986); 2
Å autosomal recessive with incomplete penetrance, as suggested by Liston and Kilpatrick (1991); 3 Å genetic
model with partial dominance, derived from Arngrı´msson et al. (1995); 4 Å autosomal dominant with 90%
penetrance; and 5 Å affecteds-only analysis.
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Figure 1 Multiallelic statistic. The TDT likelihood differences (02ln(L)diff.) for each marker in a 4-cM region around the eNOS gene
are shown for combined family data, as well as for Scottish and Icelandic families separately. The maximum-likelihood estimate of lTDT is .89,
.90, and .81 for the combined, Scottish, and Icelandic data, respectively.
different susceptibility genes and environmental factors. accurately formulated (Durner and Greenberg 1992).
New nonparametric methods designed to detect linkageThis is also likely to be the case with preeclampsia or
pregnancy-induced hypertensive syndrome, which arises and linkage disequilibrium at a short distance from the
genetic aberrations also supported the conclusion thatonly during pregnancy. We have tested the hypothesis
that the eNOS gene might be involved in the predisposi- these markers lie within close reach of a molecular aber-
ration predisposing to familial pregnancy-induced hy-tion to familial pregnancy hypertension. Results ob-
tained in this study suggest linkage and are supported pertension. The eNOS marker did not give the most
signiﬁcant results for linkage by LOD-score calculations;by the following arguments. First, the affected-sib-pair
results are corroborated by positive ﬁndings from the the most signiﬁcant results were given by marker
D7S505 located Ç2 cM from the eNOS gene. Thesethree markers tested in the region of the eNOS gene,
which reduces the risk of the type of false-positive result results can be interpreted under the following hypothe-
sis, which is compatible with the ﬁndings at this stage.that can be observed with a single marker. Also, no
evidence of segregation distortion was observed among The eNOS gene might be one of the genes involved in
the development of the familial form of the disease, butaffected-nonaffected sib pairs. Second, parametric as
well as nonparametric methods conﬁrmed the linkage possible heterogeneity, existence of phenocopies, or in-
accurate speciﬁcation of parameters in the genetic mod-between the locus and the disease. Third, the Zmax for
the three markers did not seem to be sensitive to changes els might inﬂate the recombination value. This would
falsely position the genetic aberration for the syndromein genetic parameters, with signiﬁcant LOD scores being
observed at D7S505 for most genetic models but at dif- at some distance from the eNOS gene when the LOD-
score method is used but not when a model-free ap-ferent u values. This effect would be expected in the
presence of linkage, if the genetic parameters are not proach is applied. Indeed, the results from the TDT link-
Table 4
TDT Analyses of eNOS (CA)n Marker in Icelandic, Scottish, and Combined Family Data Classifying Patients with Severe Pregnancy-Induced
Hypertensive Disorder as Affected
SCOTTISH FAMILIES ICELANDIC FAMILIES ALL FAMILIES
No. of No. of No. of No. of No. of No. of
ALLELE Cases Controls TDTa Pb Cases Controls TDTa Pb Cases Controls TDTa Pb
10 5 5 .00 .99 5 6 .09 .98 10 11 .05 .999
14 10 1 7.36 .05 6 1 3.57 .17 16 2 10.9 .007
15 4 7 1.92 1.00 4 3 .14 .87 8 10 .02 .999
a Estimates for alleles that appear at least ﬁve times in each of the two data sets.
b Corrected for multiple testing.
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age analysis using only women with the more secure we do not have enough information about the later
health of the family members, and because the smalldiagnosis of severe pregnancy-induced disease shows
maximum distortion of independent segregation of the number of individuals in each age groupmakes compari-
son with a population cohort difﬁcult. These questionsmarker alleles at the eNOS microsatellite. It may be of
relevance that in both populations the strongest associa- can only be answered by longer follow-up on the health
of these women and of suitable controls. However, if ittion was found with allele 14 of the eNOS marker. Re-
sults obtained with the HOMOG program (Ott 1991) turns out that a genetic marker will help to deﬁne a
subset of women who not only are prone to pregnancy-were also consistent with this hypothesis, with Ç70%
of families being linked to the eNOS locus, but the re- induced hypertensive disorder but also are at greater
risk of developing cardiovascular diseases later in life,sults were not statistically signiﬁcant (data not shown).
An alternative hypothesis would specify that the eNOS this would be of fundamental medical importance. It
would have implications for the management of thesegene is not involved in the pathogenesis of the disease
but is in close proximity to the actual genetic aberration women and facilitate the study of hypertensive traits
much earlier in life.on a locus that we have identiﬁed by chance, owing to
the presence of a candidate gene in the region. A search Both angiotensin and NO affect vasoregulation. High
levels of angiotensin cause vasoconstriction, whereasfor reports of other accurately positioned candidate
genes in the region of D7S505 was not successful but NO mediates vasodilatation. During normal pregnancy,
systemic adaptation occurs, with physiological changesdoes not exclude the existence, in this region, of an
unknown gene that could only be identiﬁed by cloning in the cardiovascular circulation, leading to vasodilata-
tion and decrease in systemic vascular resistance. Thisthe genes present in the region.
Several strategies can be envisaged to establish which adaptation does not occur in severe pregnancy-induced
hypertensive disorders, and abnormalities in endothelialof these two hypotheses accounts for linkage. Among
them is the identiﬁcation of polymorphisms in the re- cell–related function have been demonstrated (Roberts
and Redman 1993). Peripheral resistance is increasedgion, which can be used in search for linkage disequilib-
rium with disease-associated alleles. (Groenendijk et al. 1984), and there is a greater sensitiv-
ity to pressor agents such as angiotensin II (Gant et al.To our knowledge, this is the ﬁrst report to show
strong evidence for linkage with the familial pregnancy- 1973). This has recently been related to a reduction of
NO synthesis (Delacretaz et al. 1995). NO produced byinduced hypertensive phenotype. Our previous report
on the angiotensinogen gene (Arngrı´msson et al. 1993), eNOS is a principal determinant of the vascular tone
(Grifﬁth et al. 1987). Once synthesized, it diffuses fromwhich was also supported by an independent association
study (Ward et al. 1993), indicated linkage with only a the endothelial cells to smooth-muscle cells, where it
induces smooth-muscle-cell relaxation by activation ofsubset of the 22 families investigated. Although the APM
method showed signiﬁcant results in that study, no sig- its second messenger, cyclic guanosine 3,5-monophos-
phate. Several lines of evidence suggest the role of NOniﬁcant evidence in favor of linkage was obtained by
use of other linkage methods—for example, by LOD- in the development of pregnancy-induced hypertension.
Pharmacological blockade of NO production in preg-score calculations using several genetic models. In a
transgenic hypertensive-animal model, the importance nant experimental animals causes changes similar to
those in humans (Yallampalli and Garﬁeld 1993; Mol-of angiotensinogen has now also been suggested, in
which interaction between the maternal angiotensinogen nar et al. 1994). Endothelial-dependent vasodilatation
has been shown to be impaired in arteries from pre-gene and the fetal/placental renin gene is described as
necessary and sufﬁcient to predispose the mother toward eclamptic women (McCarthy et al. 1993), and similar
ﬁndings have been described in nonpregnant mice lack-development of a pregnancy-induced hypertensive-like
syndrome (Takimoto et al. 1996). However, in humans ing the eNOS gene (Huang et al. 1995). Also, sera from
affected women are a more potent stimulant of NOnot all investigators have observed association or link-
age with the angiotensinogen locus (Wilton et al. 1995). production in normal endothelial cell culture than are
sera from normotensive women (Baker et al. 1995), indi-This raises the important question of clinical and molec-
ular heterogeneity in this complex disorder; for example, cating some form of a blockage of the NO-production
pathway in the endothelium of these women, with acti-it would be reasonable to ask whether family members
in our study are at higher risk of cardiovascular diseases vation of a feedback mechanism and accumulation of
substances that stimulate NO synthesis. Recent studieslater in life and, furthermore, whether families in which
the disease is linked to the eNOS-gene region are indica- show that cAMP production in the placental circulation
is reduced in hypertensive pregnancies compared withtive of a subset of pregnancy-induced hypertensive disor-
der with health implications beyond pregnancy, al- pregnancies in normotensive women (Kovacs et al.
1994).though at the time of delivery no clinical or biochemical
differences can be observed between the different sub- The cause of pregnancy-induced hypertension is still
unknown, despite decades of intense research into thesets. At present, such conclusions cannot be drawn, since
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a candidate gene involved in preeclampsia? Nat Genet 4:pathogenesis of the disease. It is interesting that evidence
114–115for linkage was obtained in these families both when
Baker PN, Davidge ST, Roberts JM (1995) Plasma fromthe more homogeneous group of women with the severe
women with preeclampsia increases endothelial cell nitricform of the disorder were classiﬁed as affected and when
oxide production. Hypertension 26:244–248women with mild disease or only transient hypertension
Blackwelder WC, Elston RC (1985) A comparison of sibpairin pregnancy were included. Apparently the familial
linkage test for disease susceptibility loci. Genet Epidemiol
form is characterized by a spectrum in which the severity 2:83–97
of the disease can be variable. It may be too early to Browne FJ, Sheumack DR (1956) Chronic hypertension fol-
draw conclusions about the possible role of genes in this lowing pre-eclamptic toxaemia: the inﬂuence of familial hy-
chromosomal region in sporadic cases of the disease, and pertension on its causation. J Obstet Gynaecol Br Com-
it is still not known whether the familial form represents monw 63:677–680
another category of hypertensive disorders. Identiﬁca- Chesley LC, Cooper DW (1986) Genetics of hypertension in
pregnancy: possible single gene control of preeclampsia andtion of different genetic loci at play in pregnancy-in-
eclampsia. Am J Obstet Gynecol 53:851–863duced hypertension will progressively help in the delin-
Cooper DW, Liston WA (1979) Genetic control of severe pre-eation of important components in the development of
eclampsia. J Med Genet 16:409–416the trait. By elucidating the mechanism of the familial
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Fasterform, these studies might also help in the understanding
sequential genetic linkage computations. Am J Hum Genetof other forms of gestational hypertension, including
53:252–263sporadic cases. In this context the identiﬁcation of pre-
Delacretaz E, De Quy N, Weber B, Vial Y, Shulz PE, Burnier
disposing alleles strongly associated with the disease
M, Brunner HR, et al (1995) Differential nitric oxide syn-
could be of assistance in the identiﬁcation of women at thase activity in human platelets during pregnancy and pre-
high risk of developing the condition and thus could eclampsia. Clin Sci 88:607–610
inﬂuence the future organization of antenatal care and Durner M, Greenberg DA (1992) Effect of heterogeneity and
management of pregnant women. assumedmode of inheritance on lod scores. Am JMed Genet
42:271–275
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